Skip to main content
logo
WITHUS PHARMACEUTICAL Co.,LTD. (KOSDAQ:330350)
South Korea flag South Korea · Delayed Price · Currency is KRW
8,820.00
-50.00 (-0.56%)
At close: Aug 24, 2026

KOSDAQ:330350 Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7,2924,9674,7857,9592,4794,264
Depreciation & Amortization
4,1724,0843,7782,8441,9481,501
Loss (Gain) From Sale of Assets
----9.04-10.78385
Asset Writedown & Restructuring Costs
1,8191,819205---
Loss (Gain) From Sale of Investments
-309.07348.82133.97-1,515352.72-979.32
Provision & Write-off of Bad Debts
-2.6-34.88-154.86110.0682.62227.95
Other Operating Activities
-821.8763.67812.04801.52401.651,698
Change in Accounts Receivable
-2,484-3,4173,847-8,072717.71,545
Change in Inventory
-1,962-2,989-85.24-6,970-840.21-242.48
Change in Accounts Payable
479.731,307-3,5703,7431,012-433.87
Change in Other Net Operating Assets
-470631.5-120.8-129.6-763.0956.29
Operating Cash Flow
7,7136,7819,630-1,2375,3808,021
Operating Cash Flow Growth
-26.47%-29.58%---32.93%890.81%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4,464-1,298-2,362-10,807-15,332-6,667
Sale of Property, Plant & Equipment
---9.0511.82-
Sale (Purchase) of Intangibles
-2,027-1,817-3,700-1,195-2,442-3,627
Investment in Securities
758.561,0591,12314,5889,846-5,257
Other Investing Activities
-27.87-37.8736956.8-30-6
Investing Cash Flow
-5,166-1,766-3,6303,223-7,892-14,935

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-16,03021,98715,47018,64911,917
Long-Term Debt Issued
---1,4002,8004,700
Total Debt Issued
19,03016,03021,98716,87021,44916,617
Short-Term Debt Repaid
--19,030-14,412-16,565-18,969-9,667
Long-Term Debt Repaid
--2,519-3,535-2,215-4,191-1,220
Total Debt Repaid
-16,547-21,549-17,946-18,779-23,159-10,887
Net Debt Issued (Repaid)
2,483-5,5194,041-1,909-1,7105,730
Issuance of Common Stock
---84.5537.54-
Repurchase of Common Stock
------35.66
Dividends Paid
---1,319--632.94-422.04
Other Financing Activities
---0.81-0.02-0.67-18.25
Financing Cash Flow
2,483-5,5192,721-1,825-2,3075,254

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
------0.03
Miscellaneous Cash Flow Adjustments
0---0--0
Net Cash Flow
5,030-503.858,720161.51-4,819-1,660

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
3,2495,4837,268-12,044-9,9521,354
Free Cash Flow Growth
-62.20%-24.56%----
Free Cash Flow Margin
2.98%5.15%7.07%-15.03%-15.39%2.36%
Free Cash Flow Per Share
246.01415.40549.86-912.45-754.70102.59
Levered Free Cash Flow
-4,156-31.761,901-13,576-10,942-3,011
Unlevered Free Cash Flow
-3,746414.92,409-13,204-10,698-2,809

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
649.85834.74785.94726.81632.38326.61
Cash Income Tax Paid
-455.69406.71,0212,029242.26
Change in Working Capital
-4,436-4,46671.13-11,428126.02924.71